The latest industry intelligence report on the Cell and Gene Therapy market performs a cautious examination of the current business environment and competitive landscape of the Cell and Gene Therapy market for the forecast period, 2020 – 2027. The report says Cell and Gene Therapy Market is expected to reach USD 6,570.0 Million by 2027,it’s Market Growth is – CAGR of 19.8%
Based on the types, the Cell and Gene Therapy market has been further classified based on geography, application and consumption capability. On the basis of the product application, the industry is bifurcated taking into consideration those in demand and are an outcome of technology advancement.
Read The Detailed Report@ https://www.emergenresearch.com/industry-report/cell-and-gene-therapy-market
Key Highlights From The Report
- By indication, large b-cell lymphoma contributed to a larger market share in 2019. Large B-cell lymphoma is a highly prevalent form of non-Hodgkin lymphoma cancer in grownups. The gene therapy employs cells from the immune system of the patients to develop a custom-made treatment to combat cancer.
- By vector type, retrovirus and gammaretrovirus dominated the market with a size of USD 390.6 million in 2019. The primary benefits of retroviral vectors are the ability to alter the RNA genome to a DNA genome that steadily incorporates into the target cell. Thus the retroviral vectors may find usage in a permanent modification of the genome of the host cell nucleus genome.
Emergen Research has segmented the global Cell and Gene Therapy Market on the basis of indication, vector type, and region:
- Indication Outlook (Revenue, USD Billion; 2017-2027)
- Acute Lymphoblastic Leukemia (ALL)
- Inherited Retinal Disease
- Large B-Cell Lymphoma
- ADA-SCID
- Others
- Vector Outlook (Revenue, USD Billion; 2017-2027)
- Lentivirus
- AAV
- Retrovirus & Gammaretrovirus
- Modified Herpes Simplex Virus
- Adenovirus
- Non-Viral Plasmid Vector
- Regional Outlook (Revenue, USD Billion; 2017-2027)
North America; Europe; Asia Pacific; Central & South America; MEA
Top companies:
Spark Therapeutics LLC, Novartis AG, Gilead Sciences Inc., Bluebird Bio, GlaxoSmithKline, Celgene Corporation, Shire PLC, Sangamo Biosciences, Voyager Therapeutics, and Dimension Therapeutics, among others.
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Cell and Gene Therapy Market Segmentation & Impact Analysis
4.1. Cell and Gene Therapy Market Material Segmentation Analysis
4.2. Industrial Outlook
Continued…
